151 related articles for article (PubMed ID: 12112451)
1. Effects of Fragile X syndrome and an FMR1 knockout mouse model on forebrain neuronal cell biology.
Churchill JD; Beckel-Mitchener A; Weiler IJ; Greenough WT
Microsc Res Tech; 2002 May; 57(3):156-8. PubMed ID: 12112451
[TBL] [Abstract][Full Text] [Related]
2. Fragile X syndrome, the Fragile X related proteins, and animal models.
Hoogeveen AT; Willemsen R; Oostra BA
Microsc Res Tech; 2002 May; 57(3):148-55. PubMed ID: 12112450
[TBL] [Abstract][Full Text] [Related]
3. Transgenic mouse model for the fragile X syndrome.
Kooy RF; D'Hooge R; Reyniers E; Bakker CE; Nagels G; De Boulle K; Storm K; Clincke G; De Deyn PP; Oostra BA; Willems PJ
Am J Med Genet; 1996 Aug; 64(2):241-5. PubMed ID: 8844056
[TBL] [Abstract][Full Text] [Related]
4. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.
Cell; 1994 Jul; 78(1):23-33. PubMed ID: 8033209
[TBL] [Abstract][Full Text] [Related]
5. Altered synaptic plasticity in a mouse model of fragile X mental retardation.
Huber KM; Gallagher SM; Warren ST; Bear MF
Proc Natl Acad Sci U S A; 2002 May; 99(11):7746-50. PubMed ID: 12032354
[TBL] [Abstract][Full Text] [Related]
6. Biology of the fragile X mental retardation protein, an RNA-binding protein.
Khandjian EW
Biochem Cell Biol; 1999; 77(4):331-42. PubMed ID: 10546896
[TBL] [Abstract][Full Text] [Related]
7. Altered mossy fiber distributions in adult Fmr1 (FVB) knockout mice.
Ivanco TL; Greenough WT
Hippocampus; 2002; 12(1):47-54. PubMed ID: 11918288
[TBL] [Abstract][Full Text] [Related]
8. A phenotypic and molecular characterization of the fmr1-tm1Cgr fragile X mouse.
Yan QJ; Asafo-Adjei PK; Arnold HM; Brown RE; Bauchwitz RP
Genes Brain Behav; 2004 Dec; 3(6):337-59. PubMed ID: 15544577
[TBL] [Abstract][Full Text] [Related]
9. Exaggerated behavioral phenotypes in Fmr1/Fxr2 double knockout mice reveal a functional genetic interaction between Fragile X-related proteins.
Spencer CM; Serysheva E; Yuva-Paylor LA; Oostra BA; Nelson DL; Paylor R
Hum Mol Genet; 2006 Jun; 15(12):1984-94. PubMed ID: 16675531
[TBL] [Abstract][Full Text] [Related]
10. Molecular phenotype of Fragile X syndrome: FMRP, FXRPs, and protein targets.
Kaufmann WE; Cohen S; Sun HT; Ho G
Microsc Res Tech; 2002 May; 57(3):135-44. PubMed ID: 12112448
[TBL] [Abstract][Full Text] [Related]
11. Fmr1 knockout mice are impaired in a leverpress escape/avoidance task.
Brennan FX; Albeck DS; Paylor R
Genes Brain Behav; 2006 Aug; 5(6):467-71. PubMed ID: 16923151
[TBL] [Abstract][Full Text] [Related]
12. [Fragile X syndrome: a model of gene-brain-behaviour relationships].
Hagerman RJ; Hagerman PJ
Rev Neurol; 2001 Oct; 33 Suppl 1():S51-7. PubMed ID: 12447820
[TBL] [Abstract][Full Text] [Related]
13. The fragile X syndrome: from molecular genetics to neurobiology.
Willemsen R; Oostra BA; Bassell GJ; Dictenberg J
Ment Retard Dev Disabil Res Rev; 2004; 10(1):60-7. PubMed ID: 14994290
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse.
Mineur YS; Sluyter F; de Wit S; Oostra BA; Crusio WE
Hippocampus; 2002; 12(1):39-46. PubMed ID: 11918286
[TBL] [Abstract][Full Text] [Related]
15. Age- and region-specific imbalances of basal amino acids and monoamine metabolism in limbic regions of female Fmr1 knock-out mice.
Gruss M; Braun K
Neurochem Int; 2004 Jul; 45(1):81-8. PubMed ID: 15082225
[TBL] [Abstract][Full Text] [Related]
16. The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo.
Mientjes EJ; Nieuwenhuizen I; Kirkpatrick L; Zu T; Hoogeveen-Westerveld M; Severijnen L; Rifé M; Willemsen R; Nelson DL; Oostra BA
Neurobiol Dis; 2006 Mar; 21(3):549-55. PubMed ID: 16257225
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of melatonin against oxidative stress in Fmr1 knockout mice: a therapeutic research model for the fragile X syndrome.
Romero-Zerbo Y; Decara J; el Bekay R; Sanchez-Salido L; Del Arco-Herrera I; de Fonseca FR; de Diego-Otero Y
J Pineal Res; 2009 Mar; 46(2):224-34. PubMed ID: 19141086
[TBL] [Abstract][Full Text] [Related]
18. [Experimental therapeutic models for fragile X syndrome].
de Diego-Otero Y
Rev Neurol; 2001 Oct; 33 Suppl 1():S70-6. PubMed ID: 12447824
[TBL] [Abstract][Full Text] [Related]
19. Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome.
Koekkoek SK; Yamaguchi K; Milojkovic BA; Dortland BR; Ruigrok TJ; Maex R; De Graaf W; Smit AE; VanderWerf F; Bakker CE; Willemsen R; Ikeda T; Kakizawa S; Onodera K; Nelson DL; Mientjes E; Joosten M; De Schutter E; Oostra BA; Ito M; De Zeeuw CI
Neuron; 2005 Aug; 47(3):339-52. PubMed ID: 16055059
[TBL] [Abstract][Full Text] [Related]
20. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
Moore CJ; Daly EM; Tassone F; Tysoe C; Schmitz N; Ng V; Chitnis X; McGuire P; Suckling J; Davies KE; Hagerman RJ; Hagerman PJ; Murphy KC; Murphy DG
Brain; 2004 Dec; 127(Pt 12):2672-81. PubMed ID: 15483045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
